Las Vegas Sands
LVS
35.81
-0.50
-1.38%
Las Vegas Sands
US · LVS
#807 by market cap
Listed 1970
35.81
-0.50
-1.38%
Live - 5344 symbols - heartbeat 72s ago
· 2026-10-08 08:36
Pre-market
35.90
+0.25%
After-hours
35.88
+0.20%
Overnight
35.80
-0.03%
- Market cap
- 23.19B
- P/E (TTM)i
- 13.88
- P/Bi
- 39.92
- EPSi
- 2.35
- Div yieldi
- 3.07%
- 52W posi
- 0%
Reader sentiment
Are you bullish or bearish on LVS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.07, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.22% YoY
Margins
- Gross margin
- 49.79%
- Operating margin
- 23.73%
- Net margin
- 12.50%
Key ratios & quality
- Enterprise valuei
- 35.14B
- Altman Z-Scorei
- 2.07
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13.73B | 12.13B | 2.94B | 4.23B | 4.11B | 10.37B | 11.30B | 13.02B |
| Gross profit | 6.76B | 6.03B | 821.00M | 1.61B | 1.65B | 5.17B | 5.52B | 6.48B |
| Selling & admin expenses | 1.48B | 1.12B | 798.00M | 831.00M | 936.00M | 1.11B | 1.15B | 1.19B |
| Research & development | 12.00M | 24.00M | 18.00M | 109.00M | 143.00M | 205.00M | 228.00M | 269.00M |
| Operating profit | 3.91B | 3.48B | -1.30B | -643.00M | -770.00M | 2.36B | 2.47B | 3.09B |
| Pretax profit | 3.33B | 3.60B | -1.88B | -1.47B | -1.39B | 1.78B | 1.96B | 2.21B |
| Tax | 375.00M | 432.00M | 24.00M | -5.00M | 154.00M | 344.00M | 208.00M | 347.00M |
| Net profit | 2.95B | 3.30B | -2.14B | -1.28B | 1.36B | 1.43B | 1.75B | 1.87B |
| Basic EPS | 3 | 4 | -2 | -1 | 2 | 2 | 2 | 2 |
| Diluted EPS | 3.07 | 3.50 | -2.21 | -1.26 | 2.40 | 1.60 | 1.96 | 2.35 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.86B | 3.18B | 3.33B | 3.65B | 3.59B | 3.15B |
| Gross profit | 1.42B | 1.64B | 1.66B | 1.77B | 1.75B | 1.48B |
| Selling & admin expenses | 273.00M | 292.00M | 308.00M | 315.00M | 302.00M | 331.00M |
| Research & development | 69.00M | 69.00M | 72.00M | 59.00M | 41.00M | 43.00M |
| Operating profit | 620.00M | 800.00M | 794.00M | 875.00M | 916.00M | 625.00M |
| Pretax profit | 471.00M | 609.00M | 582.00M | 551.00M | 748.00M | 461.00M |
| Tax | 63.00M | 90.00M | 91.00M | 103.00M | 107.00M | 88.00M |
| Net profit | 408.00M | 519.00M | 491.00M | 448.00M | 641.00M | 373.00M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.49 | 0.66 | 0.61 | 0.58 | 0.85 | 0.53 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.57B | 5.31B | 5.71B | 5.51B | 6.74B | 5.78B | 4.29B | 4.83B |
| Cash & ST investments | 4.65B | 4.23B | 2.08B | 1.85B | 6.31B | 5.11B | 3.65B | 3.84B |
| Inventory | 35.00M | 37.00M | 22.00M | 22.00M | 28.00M | 38.00M | 41.00M | 46.00M |
| Total assets | 22.55B | 23.20B | 20.81B | 20.06B | 22.04B | 21.78B | 20.67B | 21.92B |
| Total current liabilities | 3.16B | 3.22B | 2.82B | 2.57B | 3.90B | 4.42B | 5.80B | 4.22B |
| Short-term debt | 111.00M | 70.00M | 75.00M | 74.00M | 2.03B | 1.90B | 3.16B | 1.13B |
| Long-term debt | 11.87B | 12.42B | 13.93B | 14.72B | 13.95B | 12.13B | 10.59B | 14.66B |
| Total liabilities | 15,802,000,000.00 | 16,692,000,000.00 | 17,269,000,000.00 | 17,811,000,000.00 | 18,383,000,000.00 | 17,674,000,000.00 | 17,506,000,000.00 | 19,986,000,000.00 |
| Total equity | 6.75B | 6.51B | 3.54B | 2.25B | 3.66B | 4.10B | 3.16B | 1.93B |
| Retained earnings | 2.77B | 3.10B | 813.00M | -148.00M | 1.68B | 2.60B | 3.46B | 4.39B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.72B | 4.26B | 4.15B | 4.83B | 4.27B | 4.30B |
| Cash & ST investments | 3.04B | 3.45B | 3.35B | 3.84B | 3.33B | 3.38B |
| Inventory | 41.00M | 40.00M | 45.00M | 46.00M | 46.00M | 46.00M |
| Total assets | 21.25B | 21.85B | 21.50B | 21.92B | 21.18B | 19.91B |
| Total current liabilities | 6.26B | 3.50B | 4.67B | 4.22B | 4.63B | 4.31B |
| Short-term debt | 2.99B | 923.00M | 1.92B | 1.13B | 1.82B | 1.57B |
| Long-term debt | 10.86B | 14.90B | 13.85B | 14.66B | 13.90B | 13.69B |
| Total liabilities | 18,214,000,000.00 | 19,568,000,000.00 | 19,635,000,000.00 | 19,986,000,000.00 | 19,568,000,000.00 | 19,012,000,000.00 |
| Total equity | 3.03B | 2.28B | 1.87B | 1.93B | 1.61B | 897.00M |
| Retained earnings | 3.63B | 3.91B | 4.16B | 4.39B | 4.75B | 4.90B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.70B | 3.04B | -1.31B | 15.00M | -795.00M | 3.23B | 3.20B | 3.02B |
| Depreciation & amortization | 1.15B | 1.07B | 1.05B | 1.10B | 1.09B | 1.27B | 1.37B | 1.54B |
| Free cash flow | 3.75B | 1.97B | -2.54B | -824.00M | -1.58B | 1.97B | 1.62B | 1.78B |
| Dividends paid | -2.98B | -3.00B | -911.00M | 0 | 0 | -305.00M | -590.00M | -833.00M |
| Stock buybacks / issuance | -905.00M | -754.00M | -- | 0 | 0 | -505.00M | -1.75B | -2.22B |
| Ending cash balance | 4.66B | 4.24B | 2.14B | 1.93B | 6.44B | 5.23B | 3.78B | 3.97B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 526.00M | 178.00M | 1.12B | 1.20B | 731.00M | 682.00M |
| Depreciation & amortization | 377.00M | 391.00M | 389.00M | 383.00M | 378.00M | 371.00M |
| Free cash flow | 72.00M | -108.00M | 886.00M | 930.00M | 537.00M | 347.00M |
| Dividends paid | -179.00M | -246.00M | -239.00M | -169.00M | -202.00M | -328.00M |
| Stock buybacks / issuance | -416.00M | -800.00M | -500.00M | -501.00M | -753.00M | -788.00M |
| Ending cash balance | 3.16B | 3.58B | 3.48B | 3.97B | 3.46B | 3.50B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 39.63 | 49.64 | -41.30 | -38.68 | 62.34 | 30.53 | 41.30 | 72.73 |
| ROA %i | 11.16 | 11.80 | -7.66 | -4.70 | 8.70 | 5.57 | 6.81 | 7.64 |
| ROIC %i | 16.31 | 17.65 | -6.80 | -2.05 | 12.52 | 8.67 | 10.64 | 12.47 |
| 5-year avg ROE %i | 35.21 | 37.50 | 23.64 | 10.73 | 14.33 | 12.51 | 10.84 | 33.65 |
| EBIT margin %i | 27.47 | 31.49 | -45.54 | -20.15 | -16.67 | 25.00 | 23.78 | 22.73 |
| FCF / sales %i | 27.33 | 12.88 | -- | -- | -- | 18.99 | 14.37 | 13.67 |
| Current ratioi | 1.76 | 1.65 | 2.03 | 2.15 | 1.73 | 1.31 | 0.74 | 1.14 |
| Quick ratioi | 1.70 | 1.57 | 0.83 | 0.80 | 1.69 | 1.26 | 0.70 | 1.09 |
| Debt / assetsi | 53.16 | 53.85 | 67.30 | 73.76 | 72.50 | 64.42 | 66.54 | 72.01 |
| LT debt / equityi | 208.90 | 239.48 | 468.52 | 737.53 | 359.37 | 294.54 | 367.27 | 921.76 |
| Interest coveragei | 8.46 | 7.80 | -3.07 | -1.37 | -0.98 | 3.17 | 3.70 | 3.97 |
| Revenue CAGR (3Y) %i | 5.51 | 2.47 | -38.64 | -32.44 | -30.28 | 52.23 | 38.70 | 46.86 |
| Net income CAGR (3Y) %i | 7.07 | 17.13 | -- | -- | -12.11 | -- | -- | -3.88 |
| FCF CAGR (3Y) %i | 24.81 | -8.87 | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 39.21 | 49.16 | 62.28 | 72.73 | 94.53 | 134.29 |
| ROA %i | 6.14 | 6.57 | 7.26 | 7.64 | 8.68 | 8.27 |
| ROIC %i | 9.93 | 10.53 | 11.67 | 12.47 | 14.06 | 13.30 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 22.77 | 23.00 | 23.30 | 22.73 | 23.65 | 22.57 |
| FCF / sales %i | 10.55 | 4.73 | 9.91 | 13.67 | 16.34 | 19.68 |
| Current ratioi | 0.59 | 1.22 | 0.89 | 1.14 | 0.92 | 1.00 |
| Quick ratioi | 0.55 | 1.14 | 0.84 | 1.09 | 0.86 | 0.93 |
| Debt / assetsi | 65.19 | 72.40 | 73.35 | 72.01 | 74.25 | 76.66 |
| LT debt / equityi | 402.26 | 748.22 | 881.73 | 921.76 | 1,160.27 | 2,356.97 |
| Interest coveragei | 3.55 | 3.67 | 3.89 | 3.97 | 4.28 | 4.10 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Marina Bay Sands is the largest reported line at 43.75% of revenue, across 9 reported segments.
- No single line clears half of revenue; The Londoner Macao is next at 22.51%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Marina Bay Sands43.75%
The Londoner Macao22.51%
The Venetian Macao18.74%
The Parisian Macao6.91%
The Plaza Macao and Four Seasons Macao4.34%
Sands Macao3.01%
Inter-company Royalties2.63%
Ferry Operations and Other1.24%
Quote time 2026-10-08 08:36:41 · For reference only, not investment advice and not tailored to your situation.